RBR E3 ubiquitin ligases: New structures, new insights, new questions

Biochemical Journal

Volumn 458, Issue 3, 2014, Pages 421-437

  Spratt, Donald E ^a   Walden, Helen ^b   Shaw, Gary S ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Catalysis; Structure; Ubiquitin ligase; Ubiquitination

Indexed keywords

CYSTEINE; HAEM OXIDIZED IRP2 UBIQUITIN LIGASE 1; HOMOLOGOUS WITH E6 ASSOCIATED PROTEIN C TERMINUS; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; PARKIN; PROTEIN C; RING1 BRCAT RCAT E3 LIGASE DERIVATIVE; TWO RING FINGERS A DOUBLE RING FINGER LINKED E3 LIGASE; TWO RING FINGERS AND A DRIL; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CATALYSIS; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME STRUCTURE; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RING FINGER MOTIF; UBIQUITINATION;

ANIMALS; CATALYSIS; DNA REPAIR; ENZYME ACTIVATION; HUMANS; MEMBRANE PROTEINS; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPS; RNA; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84896870884     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140006     Document Type: Review

References (228)

1. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (Pubitemid 28411135)
2. Deshaies, R. J. and Joazeiro, C. A. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434
3. Metzger, M. B., Pruneda, J. N., Klevit, R. E. and Weissman, A. M. (2014) RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim. Biophys. Acta 1843, 47-60
4. Borden, K. L. and Freemont, P. S. (1996) The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6, 395-401
5. Zheng, N., Wang, P., Jeffrey, P. D. and Pavletich, N. P. (2000) Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539
6. Yin, Q., Lin, S. C., Lamothe, B., Lu, M., Lo, Y. C., Hura, G., Zheng, L., Rich, R. L., Campos, A. D., Myszka, D. G. et al. (2009) E2 interaction and dimerization in the crystal structure of TRAF6. Nat. Struct. Mol. Biol. 16, 658-666
7. Mace, P. D., Linke, K., Feltham, R., Schumacher, F. R., Smith, C. A., Vaux, D. L., Silke, J. and Day, C. L. (2008) Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J. Biol. Chem. 283, 31633-31640
8. Plechanovova, A., Jaffray, E. G., Tatham, M. H., Naismith, J. H. and Hay, R. T. (2012) Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 489, 115-120
9. Dou, H., Buetow, L., Sibbet, G. J., Cameron, K. and Huang, D. T. (2013) Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat. Struct. Mol. Biol. 20, 982-986
10. Dou, H., Buetow, L., Sibbet, G. J., Cameron, K. and Huang, D. T. (2012) BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat. Struct. Mol. Biol. 19, 876-883
11. Pruneda, J. N., Littlefield, P. J., Soss, S. E., Nordquist, K. A., Chazin, W. J., Brzovic, P. S. and Klevit, R. E. (2012) Structure of an E3:E2?Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. Mol. Cell 47, 933-942
12. Huang, L., Kinnucan, E., Wang, G., Beaudenon, S., Howley, P. M., Huibregtse, J. M. and Pavletich, N. P. (1999) Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326
13. Kee, Y. and Huibregtse, J. M. (2007) Regulation of catalytic activities of HECT ubiquitin ligases. Biochem. Biophys. Res. Commun. 354, 329-333 (Pubitemid 46161353)
14. Maspero, E., Mari, S., Valentini, E., Musacchio, A., Fish, A., Pasqualato, S. and Polo, S. (2011) Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation. EMBO Rep. 12, 342-349
15. Kamadurai, H. B., Qiu, Y., Deng, A., Harrison, J. S., Macdonald, C., Actis, M., Rodrigues, P., Miller, D. J., Souphron, J., Lewis, S. M. et al. (2013) Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3. eLife 2, e00828
16. Kamadurai, H. B., Souphron, J., Scott, D. C., Duda, D. M., Miller, D. J., Stringer, D., Piper, R. C. and Schulman, B. A. (2009) Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol. Cell 36, 1095-1102
17. Budhidarmo, R., Nakatani, Y. and Day, C. L. (2012) RINGs hold the key to ubiquitin transfer. Trends Biochem. Sci. 37, 58-65
18. Metzger, M. B., Hristova, V. A. and Weissman, A. M. (2012) HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125, 531-537
19. Scheffner, M. and Kumar, S. (2014) Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects. Biochim. Biophys. Acta 1843, 61-74
20. Marin, I. and Ferrus, A. (2002) Comparative genomics of the RBR family, including the Parkinson's disease-related gene parkin and the genes of the ariadne subfamily. Mol. Biol. Evol. 19, 2039-2050 (Pubitemid 35440440)
21. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608 (Pubitemid 28207717)
22. Marin, I., Lucas, J. I., Gradilla, A. C. and Ferrus, A. (2004) Parkin and relatives: the RBR family of ubiquitin ligases. Physiol. Genomics 17, 253-263 (Pubitemid 38924170)
23. Morett, E. and Bork, P. (1999) A novel transactivation domain in parkin. Trends Biochem. Sci. 24, 229-231 (Pubitemid 29317288)
24. Imai, Y., Soda, M. and Takahashi, R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275, 35661-35664
25. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. and Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305 (Pubitemid 30437317)
26. Zhang, Y., Gao, J., Chung, K. K., Huang, H., Dawson, V. L. and Dawson, T. M. (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. U.S.A. 97, 13354-13359
27. Moynihan, T. P., Ardley, H. C., Nuber, U., Rose, S. A., Jones, P. F., Markham, A. F., Scheffner, M. and Robinson, P. A. (1999) The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1. J. Biol. Chem. 274, 30963-30968
28. Chaugule, V. K., Burchell, L., Barber, K. R., Sidhu, A., Leslie, S. J., Shaw, G. S. and Walden, H. (2011) Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30, 2853-2867
29. Wenzel, D. M., Lissounov, A., Brzovic, P. S. and Klevit, R. E. (2011) UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105-108
30. Safadi, S. S. and Shaw, G. S. (2010) Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15. J. Biol. Chem. 285, 1424-1434
31. Fallon, L., Belanger, C. M., Corera, A. T., Kontogiannea, M., Regan-Klapisz, E., Moreau, F., Voortman, J., Haber, M., Rouleau, G., Thorarinsdottir, T. et al. (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI3K-Akt signalling. Nat. Cell Biol. 8, 834-842 (Pubitemid 44151586)
32. Yagi, H., Ishimoto, K., Hiromoto, T., Fujita, H., Mizushima, T., Uekusa, Y., Yagi-Utsumi, M., Kurimoto, E., Noda, M., Uchiyama, S. et al. (2012) A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex. EMBO Rep. 13, 462-468
33. 2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J. Biol. Chem. 284, 14978-14986
34. Trempe, J. F., Sauve, V., Grenier, K., Seirafi, M., Tang, M. Y., Menade, M., Al-Abdul-Wahid, S., Krett, J., Wong, K., Kozlov, G. et al. (2013) Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 340, 1451-1455
35. Riley, B. E., Lougheed, J. C., Callaway, K., Velasquez, M., Brecht, E., Nguyen, L., Shaler, T., Walker, D., Yang, Y., Regnstrom, K. et al. (2013) Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun. 4, 1982
36. Wauer, T. and Komander, D. (2013) Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 32, 2099-2112
37. Kelsall, I. R., Duda, D. M., Olszewski, J. L., Hofmann, K., Knebel, A., Langevin, F., Wood, N., Wightman, M., Schulman, B. A. and Alpi, A. F. (2013) TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes. EMBO J. 32, 2848-2860
38. Ikeda, F., Deribe, Y. L., Skanland, S. S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M., van Wijk, S. J., Goswami, P., Nagy, V., Terzic, J. et al. (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641
39. Sato, Y., Fujita, H., Yoshikawa, A., Yamashita, M., Yamagata, A., Kaiser, S. E., Iwai, K. and Fukai, S. (2011) Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc. Natl. Acad. Sci. U.S.A. 108, 20520-20525
40. Allen, M. D., Buchberger, A. and Bycroft, M. (2006) The PUB domain functions as a p97 binding module in human peptide N-glycanase. J. Biol. Chem. 281, 25502-25508 (Pubitemid 44401939)
41. Kaustov, L., Lukin, J., Lemak, A., Duan, S., Ho, M., Doherty, R., Penn, L. Z. and Arrowsmith, C. H. (2007) The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53. J. Biol. Chem. 282, 11300-11307 (Pubitemid 47100758)
42. Duda, D. M., Olszewski, J. L., Schuermann, J. P., Kurinov, I., Miller, D. J., Nourse, A., Alpi, A. F. and Schulman, B. A. (2013) Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an ariadne-family E3 and insights into ligation mechanism. Structure 21, 1030-1041
43. Stieglitz, B., Rana, R. R., Koliopoulos, M. G., Morris-Davies, A. C., Schaeffer, V., Christodoulou, E., Howell, S., Brown, N. R., Dikic, I. and Rittinger, K. (2013) Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature 503, 422-426
44. Smit, J. J., Monteferrario, D., Noordermeer, S. M., van Dijk, W. J., van der Reijden, B. A. and Sixma, T. K. (2012) The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension. EMBO J. 31, 3833-3844
45. Stieglitz, B., Morris-Davies, A. C., Koliopoulos, M. G., Christodoulou, E. and Rittinger, K. (2012) LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. EMBO Rep. 13, 840-846
46. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902 (Pubitemid 32635090)
47. Olzmann, J. A., Li, L., Chudaev, M. V., Chen, J., Perez, F. A., Palmiter, R. D. and Chin, L. S. (2007) Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol. 178, 1025-1038 (Pubitemid 47443324)
48. Spratt, D. E., Julio Martinez-Torres, R., Noh, Y. J., Mercier, P., Manczyk, N., Barber, K. R., Aguirre, J. D., Burchell, L., Purkiss, A., Walden, H. and Shaw, G. S. (2013) A molecular explanation for the recessive nature of parkin-linked Parkinson's disease. Nat. Commun. 4, 1983
49. Ziviani, E., Tao, R. N. and Whitworth, A. J. (2010) Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. U.S.A. 107, 5018-5023
50. Narendra, D., Tanaka, A., Suen, D. F. and Youle, R. J. (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795-803
51. Tanaka, A., Cleland, M. M., Xu, S., Narendra, D. P., Suen, D. F., Karbowski, M. and Youle, R. J. (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191, 1367-1380
52. Poole, A. C., Thomas, R. E., Yu, S., Vincow, E. S. and Pallanck, L. (2010) The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS ONE 5, e10054
53. Gegg, M. E., Cooper, J. M., Chau, K. Y., Rojo, M., Schapira, A. H. and Taanman, J. W. (2010) Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet. 19, 4861-4870
54. Glauser, L., Sonnay, S., Stafa, K. and Moore, D. J. (2011) Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J. Neurochem. 118, 636-645
55. Lazarou, M., Narendra, D. P., Jin, S. M., Tekle, E., Banerjee, S. and Youle, R. J. (2013) PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding. J. Cell Biol. 200, 163-172
56. Chen, Y. and Dorn, G. W., 2nd. (2013) PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340, 471-475
57. Rakovic, A., Grunewald, A., Kottwitz, J., Bruggemann, N., Pramstaller, P. P., Lohmann, K. and Klein, C. (2011) Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS ONE 6, e16746
58. Bertolin, G., Ferrando-Miguel, R., Jacoupy, M., Traver, S., Grenier, K., Greene, A. W., Dauphin, A., Waharte, F., Bayot, A., Salamero, J. et al. (2013) The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance. Autophagy 9, 1801-1817
59. Zanon, A., Rakovic, A., Blankenburg, H., Doncheva, N. T., Schwienbacher, C., Serafin, A., Alexa, A., Weichenberger, C. X., Albrecht, M., Klein, C. et al. (2013) Profiling of parkin-binding partners using tandem affinity purification. PLoS ONE 8, e78648
60. Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S. and Selkoe, D. J. (2001) Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269 (Pubitemid 32694735)
61. Doss-Pepe, E. W., Chen, L. and Madura, K. (2005) α-Synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. J. Biol. Chem. 280, 16619-16624 (Pubitemid 41389118)
62. Kawahara, K., Hashimoto, M., Bar-On, P., Ho, G. J., Crews, L., Mizuno, H., Rockenstein, E., Imam, S. Z. and Masliah, E. (2008) α-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease. J. Biol. Chem. 283, 6979-6987
63. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K. I. and Takahashi, R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 10, 55-67 (Pubitemid 34876562)
64. Moszczynska, A., Saleh, J., Zhang, H., Vukusic, B., Lee, F. J. and Liu, F. (2007) Parkin disrupts the α-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. J. Mol. Neurosci. 32, 217-227 (Pubitemid 47574970)
65. Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S. et al. (2009) Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123-132
66. Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J., Warnken, U., Wenger, T. et al. (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844
67. Niu, J., Shi, Y., Iwai, K. and Wu, Z. H. (2011) LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 30, 3741-3753
68. Kao, S. Y. (2009) Regulation of DNA repair by parkin. Biochem. Biophys. Res. Commun. 382, 321-325
69. Kao, S. Y. (2009) DNA damage induces nuclear translocation of parkin. J. Biomed. Sci. 16, 67
70. Jiang, Q., Ren, Y. and Feng, J. (2008) Direct binding with histone deacetylase 6 mediates the reversible recruitment of parkin to the centrosome. J. Neurosci. 28, 12993-13002
71. Hebron, M. L., Lonskaya, I., Sharpe, K., Weerasinghe, P. P., Algarzae, N. K., Shekoyan, A. R. and Moussa, C. E. (2013) Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J. Biol. Chem. 288, 4103-4115
72. Okui, M., Yamaki, A., Takayanagi, A., Kudoh, J., Shimizu, N. and Shimizu, Y. (2005) Transcription factor single-minded 2 (SIM2) is ubiquitinated by the RING-IBR-RING-type E3 ubiquitin ligases. Exp. Cell Res. 309, 220-228 (Pubitemid 41191236)
73. He, B., Minges, J. T., Lee, L. W. and Wilson, E. M. (2002) The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J. Biol. Chem. 277, 10226-10235 (Pubitemid 34968137)
74. van de Wijngaart, D. J., van Royen, M. E., Hersmus, R., Pike, A. C., Houtsmuller, A. B., Jenster, G., Trapman, J. and Dubbink, H. J. (2006) Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J. Biol. Chem. 281, 19407-19416 (Pubitemid 44035446)
75. Cho, P. F., Poulin, F., Cho-Park, Y. A., Cho-Park, I. B., Chicoine, J. D., Lasko, P. and Sonenberg, N. (2005) A new paradigm for translational control: inhibition via 5′-3′ mRNA tethering by Bicoid and the eIF4E cognate 4EHP. Cell 121, 411-423 (Pubitemid 40692301)
76. Tan, N. G., Ardley, H. C., Scott, G. B., Rose, S. A., Markham, A. F. and Robinson, P. A. (2003) Human homologue of ariadne promotes the ubiquitylation of translation initiation factor 4E homologous protein, 4EHP. FEBS Lett. 554, 501-504 (Pubitemid 37412539)
77. Um, J. W. and Chung, K. C. (2006) Functional modulation of parkin through physical interaction with SUMO-1. J. Neurosci. Res. 84, 1543-1554 (Pubitemid 44683147)
78. Um, J. W., Min, D. S., Rhim, H., Kim, J., Paik, S. R. and Chung, K. C. (2006) Parkin ubiquitinates and promotes the degradation of RanBP2. J. Biol. Chem. 281, 3595-3603 (Pubitemid 43845977)
79. Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J., Yokoyama, S., Yamada, S., Kawahara, H., Yokosawa, H., Hattori, N., Mizuno, Y. et al. (2003) Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301-306 (Pubitemid 36511728)
80. Uchiki, T., Kim, H. T., Zhai, B., Gygi, S. P., Johnston, J. A., O'Bryan, J. P. and Goldberg, A. L. (2009) The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition. J. Biol. Chem. 284, 12622-12632
81. Beasley, S. A., Safadi, S. S., Barber, K. R. and Shaw, G. S. (2012) Solution structure of the E3 ligase HOIL-1 Ubl domain. Protein Sci. 21, 1085-1092
82. Hampe, C., Ardila-Osorio, H., Fournier, M., Brice, A. and Corti, O. (2006) Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum. Mol. Genet. 15, 2059-2075 (Pubitemid 43923396)
83. Dachsel, J. C., Lucking, C. B., Deeg, S., Schultz, E., Lalowski, M., Casademunt, E., Corti, O., Hampe, C., Patenge, N., Vaupel, K. et al. (2005) Parkin interacts with the proteasome subunit α4. FEBS Lett. 579, 3913-3919
84. Bae, S., Jung, J. H., An, I. S., Kim, O. Y., Lee, M. J., Lee, J. H., Park, I. C., Lee, S. J. and An, S. (2012) TRIAD1 is negatively regulated by the MDM2 E3 ligase. Oncol. Rep. 28, 1924-1928
85. Inn, K. S., Gack, M. U., Tokunaga, F., Shi, M., Wong, L. Y., Iwai, K. and Jung, J. U. (2011) Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol. Cell 41, 354-365
86. Gack, M. U., Shin, Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S. and Jung, J. U. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (Pubitemid 46633167)
87. Rivkin, E., Almeida, S. M., Ceccarelli, D. F., Juang, Y. C., MacLean, T. A., Srikumar, T., Huang, H., Dunham, W. H., Fukumura, R., Xie, G. et al. (2013) The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 498, 318-324
88. Skaar, J. R., Florens, L., Tsutsumi, T., Arai, T., Tron, A., Swanson, S. K., Washburn, M. P. and DeCaprio, J. A. (2007) PARC and CUL7 form atypical cullin RING ligase complexes. Cancer Res. 67, 2006-2014 (Pubitemid 46424217)
89. Jones, J., Wu, K., Yang, Y., Guerrero, C., Nillegoda, N., Pan, Z. Q. and Huang, L. (2008) A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J. proteome Res. 7, 1274-1287
90. Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M. and Ross, C. A. (2005) Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102, 18676-18681 (Pubitemid 43011285)
91. Lim, M. K., Kawamura, T., Ohsawa, Y., Ohtsubo, M., Asakawa, S., Takayanagi, A. and Shimizu, N. (2007) Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination. Exp. Cell Res. 313, 2858-2874 (Pubitemid 47126433)
92. Fallon, L., Moreau, F., Croft, B. G., Labib, N., Gu, W. J. and Fon, E. A. (2002) Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 277, 486-491 (Pubitemid 34952083)
93. Joch, M., Ase, A. R., Chen, C. X., MacDonald, P. A., Kontogiannea, M., Corera, A. T., Brice, A., Seguela, P. and Fon, E. A. (2007) Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Mol. Biol. Cell 18, 3105-3118 (Pubitemid 47235315)
94. Avraham, E., Rott, R., Liani, E., Szargel, R. and Engelender, S. (2007) Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J. Biol. Chem. 282, 12842-12850 (Pubitemid 47100582)
95. Rubio de la Torre, E., Luzon-Toro, B., Forte-Lago, I., Minguez-Castellanos, A., Ferrer, I. and Hilfiker, S. (2009) Combined kinase inhibition modulates parkin inactivation. Hum. Mol. Genet. 18, 809-823
96. Imam, S. Z., Zhou, Q., Yamamoto, A., Valente, A. J., Ali, S. F., Bains, M., Roberts, J. L., Kahle, P. J., Clark, R. A. and Li, S. (2011) Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease. J. Neurosci. 31, 157-163
97. Ko, H. S., Lee, Y., Shin, J. H., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletnikova, O., Troncoso, J. C., Dawson, V. L. and Dawson, T. M. (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc. Natl. Acad. Sci. U.S.A. 107, 16691-16696
98. Yamamoto, A., Friedlein, A., Imai, Y., Takahashi, R., Kahle, P. J. and Haass, C. (2005) Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J. Biol. Chem. 280, 3390-3399 (Pubitemid 40223802)
99. Kim, Y., Park, J., Kim, S., Song, S., Kwon, S. K., Lee, S. H., Kitada, T., Kim, J. M. and Chung, J. (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem. Biophys. Res. Commun. 377, 975-980
100. Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H. I., Campbell, D. G., Gourlay, R., Burchell, L., Walden, H., Macartney, T. J., Deak, M. et al. (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol. 2, 120080
101. Shiba-Fukushima, K., Imai, Y., Yoshida, S., Ishihama, Y., Kanao, T., Sato, S. and Hattori, N. (2012) PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci. Rep. 2, 1002
102. Iguchi, M., Kujuro, Y., Okatsu, K., Koyano, F., Kosako, H., Kimura, M., Suzuki, N., Uchiyama, S., Tanaka, K. and Matsuda, N. (2013) Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation. J. Biol. Chem. 288, 22019-22032
103. Fearns, C., Pan, Q., Mathison, J. C. and Chuang, T. H. (2006) Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding. J. Biol. Chem. 281, 34592-34600 (Pubitemid 46036665)
104. Bromann, P. A., Weiner, J. A., Apel, E. D., Lewis, R. M. and Sanes, J. R. (2004) A putative ariadne-like E3 ubiquitin ligase (PAUL) that interacts with the muscle-specific kinase (MuSK). Gene Expr. Patterns 4, 77-84 (Pubitemid 37498297)
105. Nakamura, M., Tokunaga, F., Sakata, S. and Iwai, K. (2006) Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex. Biochem. Biophys. Res. Commun. 351, 340-347 (Pubitemid 44666695)
106. Chan, N. C., Salazar, A. M., Pham, A. H., Sweredoski, M. J., Kolawa, N. J., Graham, R. L., Hess, S. and Chan, D. C. (2011) Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 20, 1726-1737
107. Sarraf, S. A., Raman, M., Guarani-Pereira, V., Sowa, M. E., Huttlin, E. L., Gygi, S. P. and Harper, J. W. (2013) Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496, 372-376
108. Cole, A. R., Lewis, L. P. and Walden, H. (2010) The structure of the catalytic subunit FANCL of the Fanconi anemia core complex. Nat. Struct. Mol. Biol. 17, 294-298
109. Tashiro, M., Okubo, S., Shimotakahara, S., Hatanaka, H., Yasuda, H., Kainosho, M., Yokoyama, S. and Shindo, H. (2003) NMR structure of ubiquitin-like domain in PARKIN: gene product of familial Parkinson's disease. J. Biomol. NMR 25, 153-156 (Pubitemid 36267006)
110. Bai, J. J., Safadi, S. S., Mercier, P., Barber, K. R. and Shaw, G. S. (2013) Ataxin-3 is a multivalent ligand for the parkin ubl domain. Biochemistry 52, 7369-7376
111. Trempe, J. F., Chen, C. X., Grenier, K., Camacho, E. M., Kozlov, G., McPherson, P. S., Gehring, K. and Fon, E. A. (2009) SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination. Mol. Cell 36, 1034-1047
112. Zhang, D., Raasi, S. and Fushman, D. (2008) Affinity makes the difference: nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and polyubiquitin chains. J. Mol. Biol. 377, 162-180
113. Alam, S. L., Sun, J., Payne, M., Welch, B. D., Blake, B. K., Davis, D. R., Meyer, H. H., Emr, S. D. and Sundquist, W. I. (2004) Ubiquitin interactions of NZF zinc fingers. EMBO J. 23, 1411-1421 (Pubitemid 38579502)
114. Ardley, H. C., Tan, N. G., Rose, S. A., Markham, A. F. and Robinson, P. A. (2001) Features of the parkin/ariadne-like ubiquitin ligase, HHARI, that regulate its interaction with the ubiquitin-conjugating enzyme, Ubch7. J. Biol. Chem. 276, 19640-19647
115. Regnstrom, K., Yan, J., Nguyen, L., Callaway, K., Yang, Y., Diep, L., Xing, W., Adhikari, A., Beroza, P., Hom, R. K. et al. (2013) Label free fragment screening using surface plasmon resonance as a tool for fragment finding: analyzing parkin, a difficult CNS target. PLoS ONE 8, e66879
116. Beasley, S. A., Hristova, V. A. and Shaw, G. S. (2007) Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 104, 3095-3100 (Pubitemid 46364119)
117. Spratt, D. E., Mercier, P. and Shaw, G. S. (2013) Structure of the HHARI catalytic domain shows glimpses of a HECT E3 ligase. PLoS ONE 8, e74047
118. Boudreaux, D. A., Maiti, T. K., Davies, C. W. and Das, C. (2010) Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation. Proc. Natl. Acad. Sci. U.S.A. 107, 9117-9122
119. Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J. W., Gu, W., Cohen, R. E. and Shi, Y. (2002) Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041-1054 (Pubitemid 36050118)
120. Messick, T. E., Russell, N. S., Iwata, A. J., Sarachan, K. L., Shiekhattar, R., Shanks, J. R., Reyes-Turcu, F. E., Wilkinson, K. D. and Marmorstein, R. (2008) Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein. J. Biol. Chem. 283, 11038-11049
121. Schlieker, C., Weihofen, W. A., Frijns, E., Kattenhorn, L. M., Gaudet, R. and Ploegh, H. L. (2007) Structure of a herpesvirus-encoded cysteine protease reveals a unique class of deubiquitinating enzymes. Mol. Cell 25, 677-687 (Pubitemid 46341922)
122. Maspero, E., Valentini, E., Mari, S., Cecatiello, V., Soffientini, P., Pasqualato, S. and Polo, S. (2013) Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. Nat. Struct. Mol. Biol. 20, 696-701
123. Walden, H. and Martinez-Torres, R. J. (2012) Regulation of Parkin E3 ubiquitin ligase activity. Cell. Mol. Life Sci. 69, 3053-3067
124. Zheng, X. and Hunter, T. (2013) Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism. Cell Res. 23, 886-897
125. Matsuda, N., Kitami, T., Suzuki, T., Mizuno, Y., Hattori, N. and Tanaka, K. (2006) Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro. J. Biol. Chem. 281, 3204-3209 (Pubitemid 43845931)
126. Chew, K. C., Matsuda, N., Saisho, K., Lim, G. G., Chai, C., Tan, H. M., Tanaka, K. and Lim, K. L. (2011) Parkin mediates apparent E2-independent monoubiquitination in vitro and contains an intrinsic activity that catalyzes polyubiquitination. PLoS ONE 6, e19720
127. Tsai, Y. C., Fishman, P. S., Thakor, N. V. and Oyler, G. A. (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem. 278, 22044-22055 (Pubitemid 36792614)
128. Yao, D., Gu, Z., Nakamura, T., Shi, Z. Q., Ma, Y., Gaston, B., Palmer, L. A., Rockenstein, E. M., Zhang, Z., Masliah, E., Uehara, T. and Lipton, S. A. (2004) Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. U.S.A. 101, 10810-10814 (Pubitemid 38955824)
129. Chung, K. K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J. C., Marsh, L., Dawson, V. L. and Dawson, T. M. (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328-1331 (Pubitemid 38697430)
130. Um, J. W., Han, K. A., Im, E., Oh, Y., Lee, K. and Chung, K. C. (2012) Neddylation positively regulates the ubiquitin E3 ligase activity of parkin. J. Neurosci. Res. 90, 1030-1042
131. Nikolaev, A. Y., Li, M., Puskas, N., Qin, J. and Gu, W. (2003) Parc: a cytoplasmic anchor for p53. Cell 112, 29-40 (Pubitemid 36106416)
132. Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735-749 (Pubitemid 36288547)
133. Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W. et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596
134. Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S., Tanaka, K., Nakano, H. and Iwai, K. (2011) SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636
135. Muller-Rischart, A. K., Pilsl, A., Beaudette, P., Patra, M., Hadian, K., Funke, M., Peis, R., Deinlein, A., Schweimer, C., Kuhn, P. H. et al. (2013) The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol. Cell 49, 908-921
136. Tomoo, K., Mukai, Y., In, Y., Miyagawa, H., Kitamura, K., Yamano, A., Shindo, H. and Ishida, T. (2008) Crystal structure and molecular dynamics simulation of ubiquitin-like domain of murine parkin. Biochim. Biophys. Acta 1784, 1059-1067
137. Martinez-Noel, G., Muller, U. and Harbers, K. (2001) Identification of molecular determinants required for interaction of ubiquitin-conjugating enzymes and RING finger proteins. Eur. J. Biochem. 268, 5912-5919 (Pubitemid 33079327)
138. Choi, P., Snyder, H., Petrucelli, L., Theisler, C., Chong, M., Zhang, Y., Lim, K., Chung, K. K., Kehoe, K., D'Adamio, L. et al. (2003) SEPT5-v2 is a parkin-binding protein. Brain Res. Mol. Brain Res. 117, 179-189 (Pubitemid 38366031)
139. Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., Fantaneanu, T., Paulson, H. L. and Fon, E. A. (2011) The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum. Mol. Genet. 20, 141-154
140. Durcan, T. M., Kontogiannea, M., Bedard, N., Wing, S. S. and Fon, E. A.
141. Chung, K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L. and Dawson, T. M. (2001) Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 7, 1144-1150 (Pubitemid 33010024)
142. Asai, H., Hirano, M., Kiriyama, T., Ikeda, M. and Ueno, S. (2010) Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism. Biochem. Biophys. Res. Commun. 391, 800-805
143. Sato, S., Chiba, T., Sakata, E., Kato, K., Mizuno, Y., Hattori, N. and Tanaka, K. (2006) 14-3-3η is a novel regulator of parkin ubiquitin ligase. EMBO J. 25, 211-221 (Pubitemid 43077309)
144. Shin, J. H., Ko, H. S., Kang, H., Lee, Y., Lee, Y. I., Pletinkova, O., Troconso, J. C., Dawson, V. L. and Dawson, T. M. (2011) PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell 144, 689-702
145. Xiong, H., Wang, D., Chen, L., Choo, Y. S., Ma, H., Tang, C., Xia, K., Jiang, W., Ronai, Z., Zhuang, X. and Zhang, Z. (2009) Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest. 119, 650-660
146. Sriram, S. R., Li, X., Ko, H. S., Chung, K. K., Wong, E., Lim, K. L., Dawson, V. L. and Dawson, T. M. (2005) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum. Mol. Genet. 14, 2571-2586 (Pubitemid 41236069)
147. Haskin, J., Szargel, R., Shani, V., Mekies, L. N., Rott, R., Lim, G. G., Lim, K. L., Bandopadhyay, R., Wolosker, H. and Engelender, S. (2013) AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease. Hum. Mol. Genet. 22, 2083-2096
148. Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J. C., Pradier, L., Ruberg, M., Mirande, M. et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum. Mol. Genet. 12, 1427-1437 (Pubitemid 36758455)
149. Ko, H. S., von Coelln, R., Sriram, S. R., Kim, S. W., Chung, K. K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E. L. et al. (2005) Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci. 25, 7968-7978 (Pubitemid 41254399)
150. Zhong, L., Tan, Y., Zhou, A., Yu, Q. and Zhou, J. (2005) RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity. J. Biol. Chem. 280, 9425-9430 (Pubitemid 40409636)
151. Chen, D., Gao, F., Li, B., Wang, H., Xu, Y., Zhu, C. and Wang, G. (2010) Parkin mono-ubiquitinates Bcl-2 and regulates autophagy. J. Biol. Chem. 285, 38214-38223
152. Kalia, S. K., Lee, S., Smith, P. D., Liu, L., Crocker, S. J., Thorarinsdottir, T. E., Glover, J. R., Fon, E. A., Park, D. S. and Lozano, A. M. (2004) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron 44, 931-945 (Pubitemid 39643090)
153. Wang, X., Guo, J., Jiang, H., Shen, L. and Tang, B. (2010) [Direct interaction between BAG5 protein and Parkin protein]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35, 1156-1161
154. Rawal, N., Corti, O., Sacchetti, P., Ardilla-Osorio, H., Sehat, B., Brice, A. and Arenas, E. (2009) Parkin protects dopaminergic neurons from excessive Wnt/β-catenin signaling. Biochem. Biophys. Res. Commun. 388, 473-478
155. Kuroda, Y., Sako, W., Goto, S., Sawada, T., Uchida, D., Izumi, Y., Takahashi, T., Kagawa, N., Matsumoto, M., Matsumoto, M. et al. (2012) Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential. Hum. Mol. Genet. 21, 991-1003
156. Veeriah, S., Taylor, B. S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., Janakiraman, M., Schultz, N., Hanrahan, A. J., Pao, W. et al. (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42, 77-82
157. Moore, D. J., Zhang, L., Troncoso, J., Lee, M. K., Hattori, N., Mizuno, Y., Dawson, T. M. and Dawson, V. L. (2005) Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14, 71-84 (Pubitemid 40123464)
158. Chang, C., Wu, G., Gao, P., Yang, L., Liu, W. and Zuo, J. (2013) Upregulated Parkin expression protects mitochondrial homeostasis in DJ-1 konckdown cells and cells overexpressing the DJ-1 L166P mutation. Mol. Cell. Biochem. 387, 187-195
159. Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., Selkoe, D., Rice, S., Steen, J., LaVoie, M. J. and Schwarz, T. L. (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893-906
160. Liu, S., Sawada, T., Lee, S., Yu, W., Silverio, G., Alapatt, P., Millan, I., Shen, A., Saxton, W., Kanao, T. et al. (2012) Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet. 8, e1002537
161. Yang, H., Zhou, X., Liu, X., Yang, L., Chen, Q., Zhao, D., Zuo, J. and Liu, W. (2011) Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin. Biochem. Biophys. Res. Commun. 410, 114-120
162. Rose, J. M., Novoselov, S. S., Robinson, P. A. and Cheetham, M. E. (2011) Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1 domain mutant. Hum. Mol. Genet. 20, 16-27
163. Imai, Y., Soda, M., Murakami, T., Shoji, M., Abe, K. and Takahashi, R. (2003) A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death. J. Biol. Chem. 278, 51901-51910 (Pubitemid 38020437)
164. Um, J. W., Stichel-Gunkel, C., Lubbert, H., Lee, G. and Chung, K. C. (2009) Molecular interaction between parkin and PINK1 in mammalian neuronal cells. Mol. Cell. Neurosci. 40, 421-432
165. Shiba, K., Arai, T., Sato, S., Kubo, S., Ohba, Y., Mizuno, Y. and Hattori, N. (2009) Parkin stabilizes PINK1 through direct interaction. Biochem. Biophys. Res. Commun. 383, 331-335
166. Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S. et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. U.S.A. 107, 378-383
167. Geisler, S., Holmstrom, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J. and Springer, W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12, 119-131
168. Geisler, S., Holmstrom, K. M., Treis, A., Skujat, D., Weber, S. S., Fiesel, F. C., Kahle, P. J. and Springer, W. (2010) The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 6, 871-878
169. Yu, F. and Zhou, J. (2008) Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress. Neurosci. Lett. 440, 4-8
170. Kemeny, S., Dery, D., Loboda, Y., Rovner, M., Lev, T., Zuri, D., Finberg, J. P. and Larisch, S. (2012) Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein. PLoS ONE 7, e38837
171. Huynh, D. P., Scoles, D. R., Nguyen, D. and Pulst, S. M. (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 12, 2587-2597 (Pubitemid 37304682)
172. Yang, F., Jiang, Q., Zhao, J., Ren, Y., Sutton, M. D. and Feng, J. (2005) Parkin stabilizes microtubules through strong binding mediated by three independent domains. J. Biol. Chem. 280, 17154-17162 (Pubitemid 41389181)
173. Ren, Y., Zhao, J. and Feng, J. (2003) Parkin binds to α/β tubulin and increases their ubiquitination and degradation. J. Neurosci. 23, 3316-3324 (Pubitemid 36531973)
174. Zhao, J., Ren, Y., Jiang, Q. and Feng, J. (2003) Parkin is recruited to the centrosome in response to inhibition of proteasomes. J. Cell Sci. 116, 4011-4019 (Pubitemid 37279315)
175. Elmehdawi, F., Wheway, G., Szymanska, K., Adams, M., High, A. S., Johnson, C. A. and Robinson, P. A. (2013) Human homolog of Drosophila ariadne (HHARI) is a marker of cellular proliferation associated with nuclear bodies. Exp. Cell Res. 319, 161-172
176. Parelkar, S. S., Cadena, J. G., Kim, C., Wang, Z., Sugal, R., Bentley, B., Moral, L., Ardley, H. C. and Schwartz, L. M. (2012) The parkin-like human homolog of Drosophila ariadne-1 (HHARI) can induce aggresome formation in mammalian cells and is immunologically detectable in Lewy bodies. J. Mol. Neurosci. 46, 109-121
177. Marteijn, J. A., van Emst, L., Erpelinck-Verschueren, C. A., Nikoloski, G., Menke, A., de Witte, T., Lowenberg, B., Jansen, J. H. and van der Reijden, B. A. (2005) The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells. Blood 106, 4114-4123 (Pubitemid 41775916)
178. Marteijn, J. A., van der Meer, L. T., Smit, J. J., Noordermeer, S. M., Wissink, W., Jansen, P., Swarts, H. G., Hibbert, R. G., de Witte, T., Sixma, T. K. et al. (2009) The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains. Leukemia 23, 1480-1489
179. Pietschmann, K., Buchwald, M., Muller, S., Knauer, S. K., Kogl, M., Heinzel, T. and Kramer, O. H. (2012) Differential regulation of PML-RARα stability by the ubiquitin ligases SIAH1/SIAH2 and TRIAD1. Int. J. Biochem. Cell Biol. 44, 132-138
180. Marteijn, J. A., van der Meer, L. T., van Emst, L., van Reijmersdal, S., Wissink, W., de Witte, T., Jansen, J. H. and van der Reijden, B. A. (2007) Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1. Blood 110, 3128-3135 (Pubitemid 350106303)
181. Lin, A. E., Ebert, G., Ow, Y., Preston, S. P., Toe, J. G., Cooney, J. P., Scott, H. W., Sasaki, M., Saibil, S. D., Dissanayake, D. et al. (2013) ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system. Nat. Immunol. 14, 27-33
182. Bae, S., Jung, J. H., Kim, K., An, I. S., Kim, S. Y., Lee, J. H., Park, I. C., Jin, Y. W., Lee, S. J. and An, S. (2012) TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation. FEBS Lett. 586, 3057-3063
183. Jung, J. H., Lee, S. M., Bae, S., Lee, S. J., Park, I. C., Jin, Y. W., Lee, J. H. and An, S. (2010) Triad 1 induces apoptosis by p53 activation. FEBS Lett. 584, 1565-1570
184. Skaar, J. R., Arai, T. and DeCaprio, J. A. (2005) Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. Mol. Cell Biol. 25, 5579-5589 (Pubitemid 40853592)
185. Pei, X. H., Bai, F., Li, Z., Smith, M. D., Whitewolf, G., Jin, R. and Xiong, Y. (2011) Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Res. 71, 2969-2977
186. Ito, K., Adachi, S., Iwakami, R., Yasuda, H., Muto, Y., Seki, N. and Okano, Y. (2001) N-Terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8. Eur. J. Biochem. 268, 2725-2732 (Pubitemid 32853012)
187. Kang, H. Y., Yeh, S., Fujimoto, N. and Chang, C. (1999) Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem. 274, 8570-8576 (Pubitemid 29164648)
188. Yeh, S., Kang, H. Y., Miyamoto, H., Nishimura, K., Chang, H. C., Ting, H. J., Rahman, M., Lin, H. K., Fujimoto, N., Hu, Y. C. et al. (1999) Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine 11, 195-202 (Pubitemid 30013612)
189. Miyamoto, H., Rahman, M., Takatera, H., Kang, H. Y., Yeh, S., Chang, H. C., Nishimura, K., Fujimoto, N. and Chang, C. (2002) A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth. J. Biol. Chem. 277, 4609-4617 (Pubitemid 34968489)
190. Hsu, C. L., Chen, Y. L., Yeh, S., Ting, H. J., Hu, Y. C., Lin, H., Wang, X. and Chang, C. (2003) The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. J. Biol. Chem. 278, 23691-23698 (Pubitemid 36830192)
191. Hsu, C. L., Chen, Y. L., Ting, H. J., Lin, W. J., Yang, Z., Zhang, Y., Wang, L., Wu, C. T., Chang, H. C., Yeh, S. et al. (2005) Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Mol. Endocrinol. 19, 350-361 (Pubitemid 40223460)
192. Ting, H. J., Bao, B. Y., Hsu, C. L. and Lee, Y. F. (2005) Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity. Endocrine 26, 1-9
193. Hur, E., Pfaff, S. J., Payne, E. S., Gron, H., Buehrer, B. M. and Fletterick, R. J. (2004) Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol. 2, E274
194. van Royen, M. E., Cunha, S. M., Brink, M. C., Mattern, K. A., Nigg, A. L., Dubbink, H. J., Verschure, P. J., Trapman, J. and Houtsmuller, A. B. (2007) Compartmentalization of androgen receptor protein-protein interactions in living cells. J. Cell Biol. 177, 63-72 (Pubitemid 46588402)
195. Yang, Z., Chang, Y. J., Miyamoto, H., Yeh, S., Yao, J. L., di Sant'Agnese, P. A., Tsai, M. Y. and Chang, C. (2007) Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54. Endocrinology 148, 1340-1349
196. Wu, B., Piloto, S., Zeng, W., Hoverter, N. P., Schilling, T. F. and Waterman, M. L. (2013) Ring finger protein 14 is a new regulator of TCF/β-catenin-mediated transcription and colon cancer cell survival. EMBO Rep. 14, 347-355
197. Chuang, T. H. and Ulevitch, R. J. (2004) Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 5, 495-502
198. Miah, S. M., Purdy, A. K., Rodin, N. B., MacFarlane, A. W. T., Oshinsky, J., Alvarez-Arias, D. A. and Campbell, K. S. (2011) Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling. J. Immunol. 186, 2959-2969
199. Nakhaei, P., Mesplede, T., Solis, M., Sun, Q., Zhao, T., Yang, L., Chuang, T. H., Ware, C. F., Lin, R. and Hiscott, J. (2009) The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 5, e1000650
200. Feng, F., Davis, A., Lake, J. A., Carr, J., Xia, W., Burrell, C. and Li, P. (2004) Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif. J. Virol. 78, 10574-10581 (Pubitemid 39258383)
201. Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K. and Iwai, K. (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887 (Pubitemid 44607032)
202. Sasaki, Y., Sano, S., Nakahara, M., Murata, S., Kometani, K., Aiba, Y., Sakamoto, S., Watanabe, Y., Tanaka, K., Kurosaki, T. and Iwai, K. (2013) Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J. 32, 2463-2476
203. Boisson, B., Laplantine, E., Prando, C., Giliani, S., Israelsson, E., Xu, Z., Abhyankar, A., Israel, L., Trevejo-Nunez, G., Bogunovic, D. et al. (2012) Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13, 1178-1186
204. Sieber, S., Lange, N., Kollmorgen, G., Erhardt, A., Quaas, A., Gontarewicz, A., Sass, G., Tiegs, G. and Kreienkamp, H. J. (2012) Sharpin contributes to TNFα dependent NFκB activation and anti-apoptotic signalling in hepatocytes. PLoS ONE 7, e29993
205. Keusekotten, K., Elliott, P. R., Glockner, L., Fiil, B. K., Damgaard, R. B., Kulathu, Y., Wauer, T., Hospenthal, M. K., Gyrd-Hansen, M., Krappmann, D. et al. (2013) OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153, 1312-1326
206. Smit, J. J., van Dijk, W. J., El Atmioui, D., Merkx, R., Ovaa, H. and Sixma, T. K. (2013) Target specificity of the E3 ligase LUBAC for ubiquitin and NEMO relies on different minimal requirements. J. Biol. Chem. 288, 31728-31737
207. Hostager, B. S., Kashiwada, M., Colgan, J. D. and Rothman, P. B. (2011) HOIL-1L interacting protein (HOIP) is essential for CD40 signaling. PLoS ONE 6, e23061
208. Damgaard, R. B., Nachbur, U., Yabal, M., Wong, W. W., Fiil, B. K., Kastirr, M., Rieser, E., Rickard, J. A., Bankovacki, A., Peschel, C. et al. (2012) The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 46, 746-758
209. Fiil, B. K., Damgaard, R. B., Wagner, S. A., Keusekotten, K., Fritsch, M., Bekker-Jensen, S., Mailand, N., Choudhary, C., Komander, D. and Gyrd-Hansen, M. (2013) OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol. Cell 50, 818-830
210. Emmerich, C. H., Ordureau, A., Strickson, S., Arthur, J. S., Pedrioli, P. G., Komander, D. and Cohen, P. (2013) Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl. Acad. Sci. U.S.A. 110, 15247-15252
211. Verhelst, K., Carpentier, I., Kreike, M., Meloni, L., Verstrepen, L., Kensche, T., Dikic, I. and Beyaert, R. (2012) A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J. 31, 3845-3855
212. Bayle, J., Lopez, S., Iwai, K., Dubreuil, P. and De Sepulveda, P. (2006) The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins. FEBS Lett. 580, 2609-2614
213. Martinez-Noel, G., Niedenthal, R., Tamura, T. and Harbers, K. (1999) A family of structurally related RING finger proteins interacts specifically with the ubiquitin-conjugating enzyme UbcM4. FEBS Lett. 454, 257-261 (Pubitemid 29304611)
214. Huang, J., Xu, L. G., Liu, T., Zhai, Z. and Shu, H. B. (2006) The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis. FEBS Lett. 580, 940-947 (Pubitemid 43152318)
215. Benard, G., Neutzner, A., Peng, G., Wang, C., Livak, F., Youle, R. J. and Karbowski, M. (2010) IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation. EMBO J. 29, 1458-1471
216. Ng, C. C., Arakawa, H., Fukuda, S., Kondoh, H. and Nakamura, Y. (2003) p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene 22, 4449-4458 (Pubitemid 36897976)
217. Du, W., Li, J., Sipple, J., Chen, J. and Pang, Q. (2010) Cytoplasmic FANCA-FANCC complex interacts and stabilizes the cytoplasm-dislocalized leukemic nucleophosmin protein (NPMc). J. Biol. Chem. 285, 37436-37444
218. Conforti, F., Li Yang, A., Cristina Piro, M., Mellone, M., Terrinoni, A., Candi, E., Tucci, P., Thomas, G. J., Knight, R. A., Melino, G. and Sayan, B. S. (2013) PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21(WAF1) and p63. Oncogene 32, 4758-4765
219. Sayan, B. S., Yang, A. L., Conforti, F., Tucci, P., Piro, M. C., Browne, G. J., Agostini, M., Bernardini, S., Knight, R. A., Mak, T. W. and Melino, G. (2010) Differential control of TAp73 and ΔNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc. Natl. Acad. Sci. U.S.A. 107, 12877-12882
220. Taebunpakul, P., Sayan, B. S., Flinterman, M., Klanrit, P., Gaken, J., Odell, E. W., Melino, G. and Tavassoli, M. (2012) Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2. Apoptosis 17, 762-776
221. Niwa, J., Ishigaki, S., Doyu, M., Suzuki, T., Tanaka, K. and Sobue, G. (2001) A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin ligase activity. Biochem. Biophys. Res. Commun. 281, 706-713 (Pubitemid 32917858)
222. Ito, T., Niwa, J., Hishikawa, N., Ishigaki, S., Doyu, M. and Sobue, G. (2003) Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1. J. Biol. Chem. 278, 29106-29114 (Pubitemid 36935825)
223. Huang, Y., Niwa, J., Sobue, G. and Breitwieser, G. E. (2006) Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin. J. Biol. Chem. 281, 11610-11617 (Pubitemid 43855418)
224. Niwa, J., Ishigaki, S., Hishikawa, N., Yamamoto, M., Doyu, M., Murata, S., Tanaka, K., Taniguchi, N. and Sobue, G. (2002) Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J. Biol. Chem. 277, 36793-36798
225. Takeuchi, H., Niwa, J., Hishikawa, N., Ishigaki, S., Tanaka, F., Doyu, M. and Sobue, G. (2004) Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis. J. Neurochem. 89, 64-72 (Pubitemid 38420675)
226. Ishigaki, S., Hishikawa, N., Niwa, J., Iemura, S., Natsume, T., Hori, S., Kakizuka, A., Tanaka, K. and Sobue, G. (2004) Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J. Biol. Chem. 279, 51376-51385 (Pubitemid 40017885)
227. Ishigaki, S., Niwa, J., Yamada, S., Takahashi, M., Ito, T., Sone, J., Doyu, M., Urano, F. and Sobue, G. (2007) Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity. Neurobiol. Dis. 25, 331-341 (Pubitemid 46124013)
228. Niwa, J., Yamada, S., Ishigaki, S., Sone, J., Takahashi, M., Katsuno, M., Tanaka, F., Doyu, M. and Sobue, G. (2007) Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J. Biol. Chem. 282, 28087-28095 (Pubitemid 47529492)